BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9556068)

  • 1. Characterization of serum tartrate-resistant acid phosphatase and development of a direct two-site immunoassay.
    Halleen JM; Hentunen TA; Karp M; Käkönen SM; Pettersson K; Väänänen HK
    J Bone Miner Res; 1998 Apr; 13(4):683-7. PubMed ID: 9556068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-site immunoassays for osteoclastic tartrate-resistant acid phosphatase based on characterization of six monoclonal antibodies.
    Halleen JM; Karp M; Viloma S; Laaksonen P; Hellman J; Käkönen SM; Stepan JJ; Holmes S; Väänänen Hk; Pettersson K
    J Bone Miner Res; 1999 Mar; 14(3):464-9. PubMed ID: 10027912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption.
    Halleen JM; Alatalo SL; Suominen H; Cheng S; Janckila AJ; Väänänen HK
    J Bone Miner Res; 2000 Jul; 15(7):1337-45. PubMed ID: 10893682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and characterization of monoclonal antibodies to human type-5 tartrate-resistant acid phosphatase: development of a specific immunoassay of the isoenzyme in serum.
    Chamberlain P; Compston J; Cox TM; Hayman AR; Imrie RC; Reynolds K; Holmes SD
    Clin Chem; 1995 Oct; 41(10):1495-9. PubMed ID: 7586523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tartrate-resistant acid phosphatase from human bone: purification and development of an immunoassay.
    Halleen J; Hentunen TA; Hellman J; Väänänen HK
    J Bone Miner Res; 1996 Oct; 11(10):1444-52. PubMed ID: 8889844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of monoclonal antibodies specific to human tartrate-resistant acid phosphatase.
    Janckila AJ; Cardwell EM; Yam LT
    Hybridoma; 1997 Apr; 16(2):175-82. PubMed ID: 9145320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption.
    Halleen JM
    Anticancer Res; 2003; 23(2A):1027-9. PubMed ID: 12820342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of immunoassays for type-5 tartrate-resistant acid phosphatase.
    Nakasato YR; Janckila AJ; Halleen JM; Vaananen HK; Walton SP; Yam LT
    Clin Chem; 1999 Dec; 45(12):2150-7. PubMed ID: 10585347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel fragments absorbed immunocapture enzyme assay system for tartrate-resistant acid phosphatase 5b.
    Ohashi T; Igarashi Y; Mochizuki Y; Miura T; Inaba N; Katayama K; Tomonaga T; Nomura F
    Clin Chim Acta; 2007 Feb; 376(1-2):205-12. PubMed ID: 17045980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tartrate resistant acid phosphatase--TRACP-5b as a modern bone resorption marker].
    Nowak Z; Konieczna M; Saracyn M; Wańkowicz Z
    Pol Merkur Lekarski; 2008 Apr; 24(142):351-4. PubMed ID: 18634372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tartrate-resistant acid phosphatase forms complexes with alpha2-macroglobulin in serum.
    Brehme CS; Roman S; Shaffer J; Wolfert R
    J Bone Miner Res; 1999 Feb; 14(2):311-8. PubMed ID: 9933487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum tartrate-resistant acid phosphatase 5b is a specific and sensitive marker of bone resorption.
    Halleen JM; Alatalo SL; Janckila AJ; Woitge HW; Seibel MJ; Väänänen HK
    Clin Chem; 2001 Mar; 47(3):597-600. PubMed ID: 11238321
    [No Abstract]   [Full Text] [Related]  

  • 13. Tartrate-resistant acid phosphatase (TRAP) as a serum marker for bone resorption in breast cancer patients with bone metastases.
    Tauchert S; di Liberto A; Cordes T; Thill M; Salehin D; Friedrich M
    Clin Exp Obstet Gynecol; 2009; 36(4):219-25. PubMed ID: 20101852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel immunoassay for the determination of tartrate-resistant acid phosphatase 5b from rat serum.
    Alatalo SL; Peng Z; Janckila AJ; Kaija H; Vihko P; Vaananen HK; Halleen JM
    J Bone Miner Res; 2003 Jan; 18(1):134-9. PubMed ID: 12510815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species specificity of monoclonal antibodies to human tartrate-resistant acid phosphatase.
    Janckila AJ; Walton SP; Yam LT
    Biotech Histochem; 1998 Nov; 73(6):316-24. PubMed ID: 9888357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of four monoclonal antibodies to recombinant human tartrate-resistant acid phosphatase.
    Miyazaki T; Matsunaga T; Miyazaki S; Hokari S; Komoda T
    Hybrid Hybridomics; 2002 Jun; 21(3):191-5. PubMed ID: 12165145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of immunoassays for type-5 tartrate-resistant acid phosphatase in human serum.
    Miyazaki S; Igarashi M; Nagata A; Tominaga Y; Onodera K; Komoda T
    Clin Chim Acta; 2003 Mar; 329(1-2):109-15. PubMed ID: 12589973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biology and clinical significance of tartrate-resistant acid phosphatases: new perspectives on an old enzyme.
    Janckila AJ; Yam LT
    Calcif Tissue Int; 2009 Dec; 85(6):465-83. PubMed ID: 19915788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of tartrate-resistant acid phosphatase (TRAP) 5b as serum marker of bone metastases in human breast cancer.
    Capeller B; Caffier H; Sütterlin MW; Dietl J
    Anticancer Res; 2003; 23(2A):1011-5. PubMed ID: 12820340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and characterization of putative monoclonal and polyclonal antibodies against tartrate-resistant acid phosphatase.
    Nelson PN; Chambers T
    Hybridoma; 1995 Feb; 14(1):91-4. PubMed ID: 7768539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.